Doğan Rıza, Uysal Serkan, Kumbasar Ulaş, Köksal Deniz, Ancın Burcu, Tuncel Murat
Department of Thoracic Surgery, Hacettepe University School of Medicine, Ankara, Turkey.
Department of Cardiothoracic Surgery, Yale University School of Medicine, New Haven, United States of America.
Tuberk Toraks. 2021 Mar;69(1):59-64. doi: 10.5578/tt.20219907.
Postoperative complications following thoracic procedures are a major cause of morbidity and mortality. Alveolar air leaks and/or bronchopleural fistulas are associated with increased risk of infection, prolonged chest tube, and hospital stay duration and therefore generate economical concern for health care providers. A variety of surgical sealants or adhesives have been introduced to overcome this complication. Since intraoperative BioGlue® application can also cause an inflammatory reaction and mimic tumor recurrence on FDG PET-CT, in the present study we aimed to investigate its potential role in false-positive PET-CT results in patients operated for NSCLC.
Data of six patients who underwent resection for primary NSCLC at our institution (Department of Thoracic Surgery, Hacettepe University Medical Faculty) between January 2015 and December 2018 and had false positivity, due to BioGlue® application, at the bronchial stump in follow-up FDG PET-CT were retrospectively analyzed from a prospectively collected database.
One of the 6 patients was female and 5 were male. The mean age was 68 years (range, 56-79 years). The average time interval between operation and postoperative FDG-PET imaging was 4.3 months (range, 4-6 months). Follow-up FDG-PET imaging SUVmax values ranged between 3.0 and 9.0 (median: 5.33). All patients have been evaluated by FDG-PET scan following the detection of soft tissue densities at the surgical site suspicious for recurrence at their follow-up chest CT scans. Four patients underwent a bronchoscopic examination, bronchial stumps were examined and multiple biopsies were taken from suspicious nodules or tissues and sent for pathologic examination. Histopathological results revealed inflammation which is compatible with foreign body granuloma, without any suspicion for malignancy, in all cases. Two patients were solely followed-up and subsequent FDG-PET imaging after 3 months revealed complete resolution of FDG uptake.
To avoid unnecessary biopsies or surgical procedures, the possibility of false-positive results due to surgical adhesive product use should be taken into account while interpreting follow-up FDG-PET imaging results and the operative reports should be written in detail, describing which surgical materials used and their exact application sites.
胸部手术后的并发症是发病和死亡的主要原因。肺泡气漏和/或支气管胸膜瘘与感染风险增加、胸腔引流管留置时间延长以及住院时间延长相关,因此给医疗服务提供者带来经济担忧。已引入多种手术密封剂或粘合剂来克服这一并发症。由于术中应用生物胶(BioGlue®)也可引起炎症反应,并在FDG PET-CT上模拟肿瘤复发,在本研究中,我们旨在调查其在接受非小细胞肺癌手术患者的PET-CT假阳性结果中的潜在作用。
回顾性分析2015年1月至2018年12月在我院(哈杰泰佩大学医学院胸外科)接受原发性非小细胞肺癌切除术且在随访FDG PET-CT时因应用生物胶(BioGlue®)导致支气管残端出现假阳性的6例患者的数据,这些数据来自前瞻性收集的数据库。
6例患者中1例为女性,5例为男性。平均年龄为68岁(范围56 - 79岁)。手术与术后FDG-PET成像之间的平均时间间隔为4.3个月(范围4 - 6个月)。随访FDG-PET成像SUVmax值在3.0至9.0之间(中位数:5.33)。所有患者在随访胸部CT扫描发现手术部位软组织密度可疑复发后均接受了FDG-PET扫描评估。4例患者接受了支气管镜检查,检查支气管残端,并从可疑结节或组织中多次取材进行病理检查。组织病理学结果显示所有病例均为与异物肉芽肿相符的炎症,无任何恶性怀疑。2例患者仅进行了随访,3个月后的后续FDG-PET成像显示FDG摄取完全消退。
为避免不必要的活检或手术,在解读随访FDG-PET成像结果时应考虑到因使用手术粘合剂产品导致假阳性结果的可能性,并且手术报告应详细书写,描述使用了哪些手术材料及其确切应用部位。